Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites

Journal of Neurochemistry

Volumn 66, Issue 1, 1996, Pages 210-215

  De Deurwaerdère, Philippe ^a   Bonhomme, Norbert ^a   Lucas, Guillaume ^a   Le Moal, Michel ^a   Spampinato, Umberto ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

5 HT; DA release; DA uptake inhibitor; DA uptake sites; Microdialysis; Rat; Striatum

Indexed keywords

SEROTONIN RECEPTOR; SODIUM CHANNEL;

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DRUG EFFECT; DRUG PENETRATION; IN VIVO STUDY; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030034445     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66010210.x     Document Type: Article

References (28)

1. Andrews D. W., Patrick R. L., and Barchas J. (1978) The effects of 5-hydroxytryptophan and 5-hydroxytryptamine on dopamine synthesis and release in rat brain striatal synaptosomes. J. Neurochem. 30, 465-470.
2. Arbuthnott G. W., Fairbrother I. S., and Butcher S. P. (1990) Brain microdialysis studies on the control of dopamine release and metabolism in vivo. J. Neurosci. Methods 34, 73-81.
3. Azmitia E. C. and Segal M. (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179, 641-668.
4. Benloucif S. and Galloway M. P. (1991) Facilitation of dopamine release in vivo by serotonin agonists: pharmacological characterization. Eur. J. Pharmacol. 200, 1-8.
5. Blandina P., Goldfarb J., Craddock-Royal B., and Green J. P. (1989) Release of endogenous dopamine by stimulation of 5-hydroxytryptamine receptors in rat striatum. J. Pharmacol Exp. Ther. 251, 803-809.
6. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rats. Neuropharmacology 34, 269-279.
7. de Belleroche J. S. and Bradford H. F. (1980) Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine and glutamate. J. Neurochem. 35, 1227-1234.
8. De Deurwaerdère P., Bonhomme N., Le Moal M., and Spampinato U. (1995) d-Fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. J. Neurochem. 65, 1100-1108.
9. Hunt P., Kannengiesser M.-H., and Raynaud J. P. (1974) Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum. J. Pharm. Pharmacol. 26, 370-376.
10. 3H)-dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and d-amphetamine. J. Pharmacol. Exp. Ther. 262, 356-364.
11. 3 Receptors (Hamon M., ed), pp. 157-187. Academic Press, London.
12. Moghaddam B. and Bunney B. S. (1989) Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J. Neurochem. 53, 652-654.
13. Nissbrandt H., Waters N., and Hjorth S. (1992) The influence of serotonergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 346, 12-19.
14. Nomikos G. G., Damsma G., Wenkstern D., and Fibiger H. (1990) In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6, 106-112.
15. 4 receptor in the striato-nigral pathway in the rat brain. (Abstr.) Br. J. Pharmacol. 113 (Suppl.), 135P.
16. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, New York.
17. Quirion R. and Richard J. (1987) Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in the rat brain. Synapse 1, 124-130.
18. Santiago M. and Westerink B. H. C. (1990) Characterization of the in vivo release of dopamine recorded by different types of intracerebral microdialysis probes. Naunyn Schmiedebergs Arch. Pharmacol. 342, 407-414.
19. 3H]dopamine. Eur. J. Pharmacol. 167, 309-310.
20. Soubrié P., Reisine T. D., and Glowinski J. (1984) Functional aspects of serotonin transmission in the basal ganglia: a review and in vivo approach using the push-pull cannula technique. J. Neurosci. 13, 605-625.
21. Steward L. J. and Barnes N. M. (1994) The 5-HT4 receptor agonists renzapride and (s)-zacopride stimulate dopamine release from rat striatal slices. (Abstr.) Br. J. Pharmacol. 111 (Suppl.), 155P.
22. Westerink B. H. C., Tuntler J., Damsma G., Rollema H., and de Vries J. B. (1987) The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain microdialysis. Naunyn Schmiedebergs Arch. Pharmacol. 336, 502-507.
23. Westerink B. H. C., Hofsteede R. M., Tuntler J., and de Vries J. B. (1989) Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. J. Neurochem. 52, 722-728.
24. Yadid G., Pacak K., Kopin I. J., and Goldstein D. S. (1994) Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther. 270, 1158-1165.
25. Yeghiayan S. K., Kelley A. E., Campbell A., and Baldessarini R. J. (1994) Mechanism underlying orofacial stereotypy induced by serotonin microinjected into rat ventrolateral striatum. Soc. Neurosci. Abstr. 20, 377.
26. 3H]-dopamine release from rat striatal synaptosomes. Eur. J. Pharmacol. 199, 185-189.
27. +-evoked dopamine release from rat olfactory tubercle and striatal slices. Br. J. Pharmacol. 113, 968-972.
28. Zetterström T., Sharp T., Collin A. K., and Ungerstedt U. (1988) In vivo measurement of extracellular dopamine and DOPAC in the rat striatum after various dopamine-releasing drugs: implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148, 327-334.